| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-02-13 | Jones Mitchell Lawrence Chief Medical Officer | Sale | -1,989 | -13.04%13,263 | $1.75 | $3,481 | View SEC filing | |
| 2026-02-13 | Finley John David CEO, CFO | Sale | -3,896 | -12.47%27,353 | $1.75 | $6,818 | View SEC filing | |
| 2026-01-21 | Williams Donald Allen Director | Purchase | +5,000 | +87.29%10,728 | $1.67 | $8,356 | View SEC filing | |
| 2026-01-13 | Williams Donald Allen Director | Purchase | +5,000 | +686.81%5,728 | $1.88 | $9,400 | View SEC filing | |
| 2024-05-29 | Williams Donald Allen Director | Purchase | +1,000 | +100.00%1,000 | $4.86 | $4,863 | View SEC filing | |
| 2024-05-28 | Finley John David CEO, CFO, Director | Purchase | +1,000 | +13.45%8,437 | $4.81 | $4,810 | View SEC filing | |
| 2024-02-07 | Finley John David CEO, CFO, Director | Purchase | +10,000 | +13.40%84,649 | $0.47 | $4,692 | View SEC filing | |
| 2024-02-01 | Finley John David CEO, CFO, Director | Purchase | +10,000 | +15.47%74,649 | $0.56 | $5,590 | View SEC filing | |
| 2024-02-01 | Williams Donald Allen Director | Purchase | +10,000 | +50.00%30,000 | $0.60 | $6,050 | View SEC filing | |
| 2023-09-29 | Williams Donald Allen Director | Purchase | +20,000 | +100.00%20,000 | $0.54 | $10,800 | View SEC filing | |
| 2023-09-29 | Finley John David CEO, CFO, Director | Purchase | +15,000 | +52.83%43,394 | $0.54 | $8,088 | View SEC filing | |
| 2023-09-15 | Trenschel Robert J. Director | Sale | -300 | -100.00%0 | $0.64 | $192 | View SEC filing | |
| 2023-09-14 | Finley John David CEO, CFO, Director | Purchase | +15,000 | +111.99%28,394 | $0.66 | $9,825 | View SEC filing | |
| 2022-09-02 | Finley John David Chief Financial Officer | Purchase | +19,481.242 | +15.07%148,727.242 | $0.14 | $2,799 | View SEC filing | |
| 2022-08-25 | Finley John David Chief Financial Officer | Purchase | +7,350 | +6.03%129,246 | $0.16 | $1,176 | View SEC filing | |
| 2022-08-18 | Hallam Thomas Chief Executive Officer | Purchase | +120,000 | +682.13%137,592 | $0.08 | $10,000 | View SEC filing | |
| 2022-08-18 | Finley John David Chief Financial Officer | Purchase | +300,000 | +1370.11%321,896 | $0.08 | $25,000 | View SEC filing | |
| 2022-03-31 | Dawson Michael John Chief Medical Officer | Purchase | +15,000 | +100.00%15,000 | $1.14 | $17,093 | View SEC filing | |
| 2022-03-29 | Hallam Thomas Chief Executive Officer | Purchase | +10,000 | +131.72%17,592 | $1.18 | $11,800 | View SEC filing | |
| 2022-03-25 | Finley John David Chief Financial Officer | Purchase | +7,500 | +52.10%21,896 | $1.09 | $8,174 | View SEC filing | |
| 2021-09-22 | Finley John David Chief Financial Officer | Purchase | +2,000 | +16.13%14,396 | $2.44 | $4,880 | View SEC filing | |
| 2021-09-22 | Hallam Thomas Chief Executive Officer | Purchase | +6,000 | +376.88%7,592 | $2.49 | $14,940 | View SEC filing | |
| 2021-09-13 | Trenschel Robert J. Director | Purchase | +14,999 | +100.00%14,999 | $2.82 | $42,297 | View SEC filing | |
| 2021-08-30 | Finley John David Chief Financial Officer | Purchase | +10,000 | +417.36%12,396 | $2.65 | $26,468 | View SEC filing | |
| 2017-05-18 | Daly Richard J Chief Executive Officer | Purchase | +7,500 | +47.43%23,312 | $4.00 | $30,000 | View SEC filing |
1-25 of 79
